Slashdot Mirror

← Back to Stories (view on slashdot.org)

India's "$10 Laptop" To Cost $100 After All

Posted by timothy on from the ain't-it-the-way-of-things dept.

narramissic writes "In case you missed it, India's Minister of State for Higher Education yesterday announced the development of a $10 laptop that will target higher education applications. There were no specifications given for the laptop and the rock-bottom price raised questions about government subsidies. Today, the figure was corrected: It's not a $10 laptop; it's a $100 laptop. Still no specs though."

6 of 146 comments (clear)

  1. Give it a day... by Greenmoon · · Score: 5, Funny

    They'll have it up to $1000.

    Pesky decimal points....

  2. In before... by gparent · · Score: 5, Funny

    They must've added Windows to it?

  3. Re:With the way the US economy is going... by Anonymous Coward · · Score: 5, Funny

    hopefully the users of this laptop will have to call and talk to someone with a thick, indecipherable American accent to get tech support. Fair is fair.

  4. 100$ Laptop by geogob · · Score: 5, Funny

    Oh I see where this is going...

    Optional accessories:
    - LCD screen : 150$
    - CPU : 100$
    - 512 Mb RAM : 50$
    - Battery : 100$
    - AC Power adapter : 80$
    etc.
    There are things money can't buy, but for laptops accessories, there's mastercard.

    But yeah... I guess the laptop could be 100$ itself.
    Back to the good ol' times where GM sold there cars with "wheels" and "Steering wheel" as an option.

    1. Re:100$ Laptop by maxume · · Score: 5, Funny

      Here cars are way better than there cars. In a here car, you get in and then somebody says "We're here". In a there car, you get in and then somebody says "Are we there?".

      --
      Nerd rage is the funniest rage.
  5. Re:Common sense by reverseengineer · · Score: 5, Funny

    I'd definitely pay more than 35 cents for a candy bar whose ingredients totalled 110% of its contents, just to find out how that was possible.

    --
    "FDA staff reviewers expressed concern about the number of patients who were left out of the study because they died."